Company Filing History:
Years Active: 2001-2006
Title: Keith Roger Bley: Innovator in Pharmaceutical Chemistry
Introduction
Keith Roger Bley is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that act as IP receptor antagonists. With a total of 6 patents to his name, Bley has established himself as a key figure in his area of expertise.
Latest Patents
Among his latest patents, Bley has developed innovative compounds such as 2-(substituted-phenyl)amino-imidazoline derivatives. This invention relates to IP receptor antagonists selected from a specific group of compounds represented by a defined formula, including their pharmaceutically acceptable salts or crystal forms. Additionally, he has worked on thiophenylaminoimidazolines as IP antagonists, which involve methods for treating diseases mediated by IP antagonists through the administration of specific compounds.
Career Highlights
Throughout his career, Keith Roger Bley has worked with prominent companies in the pharmaceutical industry, including Syntex Inc. and Roche Palo Alto LLC. His work has contributed to advancements in therapeutic agents and pharmaceutical compositions.
Collaborations
Bley has collaborated with notable colleagues such as Robin D. Clark and Alam Jahangir, further enhancing his contributions to the field.
Conclusion
Keith Roger Bley is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic agents. His innovative patents and collaborations reflect his commitment to advancing medical science.